Articles related to PEER-TO-PEER

Explore the potential implications of the formation of Risant Health on community oncology, as discussed by industry experts in a recent episode of Cancer Care Business Breakthroughs. Learn about the potential challenges and opportunities this new entity could bring to the healthcare landscape.

The KEYNOTE-789 study results have sparked a debate on the role of immunotherapy in treating stage IV EGFR-mutated NSCLC. While the study did not show a significant benefit of adding pembrolizumab to chemotherapy, experts agree that the potential role of immunotherapy, particularly in combination with anti-angiogenic therapy, should not be completely dismissed.

Dr. Susan Love, a revered figure in the realm of oncology, has left a legacy of patient advocacy and innovative research, driving physicians to approach patient care and cancer research with empathy, courage, and forward-thinking dynamism.

Discover how optometrists are revolutionizing patient care by integrating aesthetic technologies into their practices, offering a comprehensive approach to ocular health and beauty.

Stay abreast with the latest ACP guidelines on the management of acute left-sided colonic diverticulitis that stress a less-aggressive approach to handling uncomplicated cases, revealing a paradigm shift in diverticulitis management.

Despite striking parallels in symptomatology between POTS and autoimmune disorders, a deeper scrutiny reveals that this overlap may not be sufficient to definitively attribute an autoimmune cause to POTS; hence, indiscriminate application of immunosuppressive therapies should be re-evaluated.